Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain
Clinical trial NCT04688671 · COMPLETED
Trial details
- NCT number
- NCT04688671
- Sponsor
- Eliem Therapeutics (UK) Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-09
- Primary completion
- 2022-02-09
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.